Sutures Versus Polyglactin Mesh in Hiatal Hernia Repair

NCT ID: NCT05201508

Last Updated: 2023-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

110 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-01-21

Study Completion Date

2043-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Paraesophageal hernia causes pain, heartburn, regurgitation, anemia and in extreme, life-threatening strangulation. For symptomatic patients, laparoscopic surgery is offered which includes hiatal defect closure and antireflux surgery. However, recurrence rates are high between 12 and 42%. In order to reduce recurrences, mesh has been used with various materials and techniques with conflicting results. Non-absorbable mesh has been linked with adverse events including erosion of esophageal wall. Traditionally used biological mesh materials are expensive and therefore problematic in routine use. Use of polyglactin (Vicryl®) mesh, which degrades in 6-8 week, has been reported in paraesophageal hernia surgery. Previously, no randomized controlled trial comparing sutures only and polyglactin mesh has been performed. In this trial, the aim was to randomize total of 110 patients to receive sutures only or mesh repair. Primary outcome was recurrence of paraesophageal hernia at 6 months after the repair based on computed tomography scan. Secondary outcomes included symptomatic recurrences, reoperation rate, quality of life, reoperations up to 20-years after surgery and use of proton pump inhibitors up to 20-years after surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Paraesophageal Hernia Hiatal Hernia Hiatal Hernia, Paraesophageal Recurrence

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Prospective open label randomized trial
Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Sutures only

Traditional suture closure of hiatal defect

Group Type ACTIVE_COMPARATOR

Sutures only

Intervention Type PROCEDURE

Traditional hiatal closure with non-absorbable sutures.

Polyglactin mesh

In addition to traditional sutures, key hole polyglactin mesh for hiatal defect closure.

Group Type EXPERIMENTAL

Polyglactin mesh

Intervention Type PROCEDURE

Polyglactin mesh is used in keyhole manner to enforce hiatal closure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Polyglactin mesh

Polyglactin mesh is used in keyhole manner to enforce hiatal closure

Intervention Type PROCEDURE

Sutures only

Traditional hiatal closure with non-absorbable sutures.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 18 years old
* Type III-IV PEH with either radiologic or endoscopic confirmation
* Scheduled for laparoscopic PEH repair
* The informed consent is acquired

Exclusion Criteria

* Need for esophagus lengthening procedure (Collis gastroplasty)
* Recurrent PEH
* Emergency surgery
* No written consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Central Finland Hospital District

OTHER

Sponsor Role collaborator

Oulu University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Olli Helminen

MD, PhD, Adjunct professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oulu University Hospital

Oulu, , Finland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Finland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Olli Helminen, MD, PhD

Role: CONTACT

+35883152011

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Olli Helminen, MD, PhD

Role: primary

+35883152011

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Sutures or mesh for PEH

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Laparoscopic Isthmocele Repair
NCT06918275 ENROLLING_BY_INVITATION NA